Glutamate decarboxylase is not genetically linked to pyridoxine-dependent seizures
- 25 July 2000
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 55 (2) , 309-311
- https://doi.org/10.1212/wnl.55.2.309
Abstract
Article abstract Several aspects of pyridoxine-dependent seizure (PDS) suggest a mutation affecting glutamate decarboxylase (GAD) as a possible cause. To examine the possibility of GAD linkage with PDS, the authors performed genotype analyses of three families using polymorphic markers near the GAD genes (GAD1 and GAD2). In each family, the affected siblings exhibited different genotypes for the GAD2 gene; in two families the GAD1 genotype was disparate. These findings suggest that a mutation of GAD is not directly involved in all cases of PDS.Keywords
This publication has 8 references indexed in Scilit:
- A Physical Map of 30,000 Human GenesScience, 1998
- Identification of a Familial Mutation Associated with GABA-Transaminase Deficiency DiseaseNeurobiology of Disease, 1998
- Longitudinal MRI findings in pyridoxine-dependent seizuresNeurology, 1998
- Current perspectives on pyridoxine-dependent seizuresThe Journal of Pediatrics, 1998
- A subtype of pyridoxine‐dependent epilepsy with normal CSF glutamate concentrationJournal of Inherited Metabolic Disease, 1998
- Mutation and polymorphic marker analyses of 65K- and 67K-glutamate decarboxylase genes in two families with pyridoxine-dependent epilepsyJournal of Human Genetics, 1998
- Cloning of a functional vesicular GABA and glycine transporter by screening of genome databasesFEBS Letters, 1997
- Linkage and Association Studies in Insulin-Dependent Diabetes with a New Dinucleotide Repeat Polymorphism at the Gad65LocusAutoimmunity, 1995